BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products... Show more
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FESMX | 11.95 | 0.11 | +0.93% |
| First Eagle U.S. SMID Cap Opportunity I | |||
| SWLVX | 62.19 | 0.25 | +0.40% |
| Schwab ® US Large-Cap Value Index | |||
| THPBX | 25.20 | 0.09 | +0.36% |
| BNY Mellon Balanced Opportunity J | |||
| PRDAX | 11.97 | -0.02 | -0.17% |
| Principal Diversified Real Asset A | |||
| PAIGX | 22.22 | -0.04 | -0.18% |
| T. Rowe Price International Value Eq Adv | |||
A.I.dvisor tells us that BGLAF and CTTH have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and CTTH's prices will move in lockstep.
| Ticker / NAME | Correlation To BGLAF | 1D Price Change % | ||
|---|---|---|---|---|
| BGLAF | 100% | N/A | ||
| CTTH - BGLAF | 23% Poorly correlated | N/A | ||
| CRYM - BGLAF | 21% Poorly correlated | N/A | ||
| SHPH - BGLAF | 8% Poorly correlated | N/A | ||
| PLNH - BGLAF | 3% Poorly correlated | +15.21% | ||
| SDZNY - BGLAF | 2% Poorly correlated | -1.34% | ||
More | ||||